Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-49.35%
End price
14.12.24
€0.82
Summary
This prediction ended on 14.12.24 with a price of €0.82. Massive losses of -49.35% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocugen Inc. | -8.290% | -8.290% | 12.859% |
| iShares Core DAX® | -2.486% | 0.323% | 0.748% |
| iShares Nasdaq 100 | -4.401% | 1.587% | 32.085% |
| iShares Nikkei 225® | -4.295% | 0.970% | 50.000% |
| iShares S&P 500 | -2.199% | 2.005% | 22.599% |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year